指南与共识产科母胎医学

产科照护共识第6号摘要:围存活期分娩

Obstetric Care Consensus No. 6 Summary: Periviable Birth.
指南 / 共识 · Obstet Gynecol · 2017-01-01

该共识将围存活期分娩定义为妊娠20 0/7周至25 6/7周的分娩,指出妊娠20周前分娩约占全部分娩的0.5%,是新生儿死亡和超过40%婴儿死亡的主要原因。文件汇总了影响围存活期分娩近远期结局的不可改变因素、可改变的产前产时因素及生后管理,并给出干预建议与家庭咨询框架,强调结合个体情况和患者价值观共同决策。

要点

  • 围存活期分娩指妊娠20 0/7周至25 6/7周的分娩
  • 计划进行母儿干预的围存活期分娩应尽量在具备母儿重症监护条件的中心进行
  • 产前产时管理包括短期宫缩抑制、抗生素及分娩方式选择等,须结合具体情况

核心结论

  • 围存活期分娩的决策复杂且涉及伦理,应基于个体情况和患者价值观,在充分告知后纳入患者偏好共同决策,包括拒绝或接受干预。

研究设计与样本

  • 美国妇产科医师学会(Obstet Gynecol)发布的产科照护共识第6号摘要,基于联合工作会议纪要界定围存活期分娩并提出循证建议与家庭咨询框架。

主要发现

  • 约0.5%的分娩发生在妊娠第三孕期之前,这些极早分娩导致大多数新生儿死亡和超过40%的婴儿死亡。
  • 围存活期分娩结局除与出生孕周相关外,还与胎儿性别、体重、多胎等不可改变因素,分娩地点、是否干预、产前皮质激素和硫酸镁使用等可改变因素,以及生后是否开始或撤除重症监护相关。
  • 产前产时管理可包括为争取产前激素给药时间的短期宫缩抑制治疗、胎膜早破后延长潜伏期的抗生素或产时B族链球菌预防用药,以及因胎儿安危或胎位异常而行的分娩包括剖宫产。

关键数值与推荐

  • 围存活期分娩定义为妊娠20 0/7周至25 6/7周的分娩。
  • 约0.5%的分娩发生在妊娠第三孕期之前,这些极早分娩导致大多数新生儿死亡和超过40%的婴儿死亡。
  • 计划进行母儿干预的围存活期分娩应尽可能在具备母儿照护专长及重症监护病房等所需基础设施的中心进行。

临床怎么用

  • 文件用于指导围存活期分娩的新生儿结局告知、干预决策及家庭咨询,帮助将知情患者偏好纳入决策;是否干预或拒绝干预应结合个体情况和患者价值观。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Approximately 0.5% of all births occur before the third trimester of pregnancy, and these very early deliveries result in the majority of neonatal deaths and more than 40% of infant deaths. A recent executive summary of proceedings from a joint workshop defined periviable birth as delivery occurring from 20 0/7 weeks to 25 6/7 weeks of gestation. When delivery is anticipated near the limit of viability, families and health care teams are faced with complex and ethically challenging decisions. Multiple factors have been found to be associated with short-term and long-term outcomes of periviable births in addition to gestational age at birth. These include, but are not limited to, nonmodifiable factors (eg, fetal sex, weight, plurality), potentially modifiable antepartum and intrapartum factors (eg, location of delivery, intent to intervene by cesarean delivery or induction for delivery, administration of antenatal corticosteroids and magnesium sulfate), and postnatal management (eg, starting or withholding and continuing or withdrawing intensive care after birth). Antepartum and intrapartum management options vary depending upon the specific circumstances but may include short-term tocolytic therapy for preterm labor to allow time for administration of antenatal steroids, antibiotics to prolong latency after preterm premature rupture of membranes or for intrapartum group B streptococci prophylaxis, and delivery, including cesarean delivery, for concern regarding fetal well-being or fetal malpresentation. Whenever possible, periviable births for which maternal or neonatal intervention is planned should occur in centers that offer expertise in maternal and neonatal care and the needed infrastructure, including intensive care units, to support such services. This document describes newborn outcomes after periviable birth, provides current evidence and recommendations regarding interventions in this setting, and provides an outline for family counseling with the goal of incorporating informed patient preferences. Its intent is to provide support and guidance regarding decisions, including declining and accepting interventions and therapies, based on individual circumstances and patient values.

来源:Obstet Gynecol,查看原文。版权归原作者所有。

引用

  1. Obstetric Care Consensus No. 6 Summary: Periviable Birth. Obstet Gynecol. 2017. PMID: 28937567. doi:10.1097/AOG.0000000000002347

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。